|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 5.250 USD | +2.34% |
|
+11.23% | +20.97% |
| 10-21 | PolyPid Ltd. Presents D-PLEX100 Microbiology Data At IDWeek 2026 | CI |
| 10-01 | PolyPid Ltd. Announces European Medicines Agency Validation Of Marketing Authorization Application For D-PLEX100 | CI |
| Market Cap | 107M 95.23M 87.97M 79.72M 149M 10.12B 152M 1.06B 419M 5.3B 400M 392M 16.72B | P/E 2026 * |
-5.9x | P/E 2027 * | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 107M 95.23M 87.97M 79.72M 149M 10.12B 152M 1.06B 419M 5.3B 400M 392M 16.72B | EV / Sales 2026 * |
7.11x | EV / Sales 2027 * | 12.3x |
| Free-Float |
87.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PYPD | Delayed | |
CBOE
| PYPD | Real-time | |
|
Deutsche Boerse AG
| 2PV | Delayed |
Last Transcript: PolyPid Ltd.
| 1 day | +2.34% | ||
| 1 week | +11.23% | ||
| Current month | -0.38% | ||
| 1 month | -2.05% | ||
| 3 months | +34.62% | ||
| 6 months | +13.64% | ||
| Current year | +20.97% |
| 1 week | 4.77 |  | 5.25 |
| 1 month | 4.61 | | 5.55 |
| Current year | 3.65 | | 5.73 |
| 1 year | 3.4 | | 5.73 |
| 3 years | 2.3 | | 9.2 |
| 5 years | 2.3 | | 257.1 |
| 10 years | 2.3 | | 583.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dikla Akselbrad
CEO | Chief Executive Officer | 52 | 2022-06-30 |
Jonny Missulawin
DFI | Director of Finance/CFO | 39 | - |
| Chief Tech/Sci/R&D Officer | 61 | 2025-08-17 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 84 | 2008-03-31 | |
Dikla Akselbrad
BRD | Director/Board Member | 52 | 2022-08-07 |
Itzhak Krinsky
BRD | Director/Board Member | 74 | 2018-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/15/26 | Free | Director | 9,132 | 0.0896% | ||
| 7/15/26 | Free | Director | 9,132 | 0.0896% | ||
| 7/15/26 | Free | Chairman | 9,132 | 0.0896% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.34% | +11.23% | +52.62% | +38.52% | 107M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.75% | +3.07% | +38.58% | +66.09% | 400.38B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15M 13.4M 12.37M 11.21M 20.98M 1.42B 21.33M 149M 58.95M 746M 56.29M 55.1M 2.35B | 8.68M 7.75M 7.16M 6.49M 12.13M 824M 12.33M 86.12M 34.1M 431M 32.56M 31.86M 1.36B |
| Net income | -20.03M -17.88M -16.52M -14.97M -28.01M -1.9B -28.47M -199M -78.71M -996M -75.16M -73.56M -3.14B | -31.55M -28.17M -26.03M -23.59M -44.13M -2.99B -44.86M -313M -124M -1.57B -118M -116M -4.95B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$5.250 | +2.34% | 104,234 |
| 26-10-22 | US$5.130 | +1.18% | 155,520 |
| 26-10-21 | US$5.070 | -1.55% | 137,081 |
| 26-10-20 | US$5.150 | +5.53% | 109,509 |
| 26-10-19 | US$4.880 | +3.39% | 110,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PYPD Stock
Select your edition
All financial news and data tailored to specific country editions
